Report Company Directory
- Dropping Coverage of Four Stocks as a Result of Reallocation of Resources by William Blair
- FDA Type-A Meeting Minutes Confirm RTF on Roluperidone NDA; Management Evaluating Next Steps by William Blair
- Fast Forward No. 631 by William Blair
- NeuroNavigator: What’s the Pulse on Novel Neuropsych Therapies? Conclusions From Surveys, Conferences, and Pricing by William Blair
- Biotech 2022 Recap and 2023 Predictions: Gene Therapy Approvals, Disruptive New Business Models, and Obesity + NASH Revivals by William Blair
- Fast Forward No. 630 by William Blair
- William Blair Biotech Team 2023 Outlook and JPM Conference Preview: Monday, December 19, at 11:00 a.m. ET by William Blair
- Fast Forward No. 629 by William Blair
- Reminder: William Blair Healthcare Research Team: 2023 Outlook and Focus Ideas—Friday, December 9, at 12 p.m. ET by William Blair
- William Blair Healthcare Research Team: 2023 Outlook and Focus Ideas—Friday, December 9, at 12 p.m. ET by William Blair